Literature DB >> 18068980

Synthesis of genistein derivatives and determination of their protective effects against vascular endothelial cell damages caused by hydrogen peroxide.

Xiao-Hua Fu1, Li Wang, Hong Zhao, Hong-Lin Xiang, Jian-Guo Cao.   

Abstract

A series of genistein derivatives, prepared by alkylation and difluoromethylation, were tested for their inhibitory effects on the hydrogen peroxide induced impairment in human umbilical vein endothelial (HUVE-12) cells in vitro. The HUVE-12 cells were pretreated with either the vehicle solvent (DMSO), genistein, or different amounts of the genistein derivatives for 30 min before exposed to 1 mM hydrogen peroxide for 24 h. Cell apoptosis was determined by flow cytometry with propidium iodide (PI) staining. Cellular injury was estimated by measuring the lactate dehydrogenase (LDH) release. Data suggested that the genistein derivatives possessed a protective effect on HUVE-12 cells from hydrogen peroxide induced apoptosis and reduced LDH release. Among these derivatives, 7-difluoromethyl-5,4'-dimethoxygenistein exhibited the strongest activity against hydrogen peroxide induced apoptosis of HUVE-12 cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18068980     DOI: 10.1016/j.bmcl.2007.11.097

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

Review 1.  Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease.

Authors:  V B Gencel; M M Benjamin; S N Bahou; R A Khalil
Journal:  Mini Rev Med Chem       Date:  2012-02       Impact factor: 3.862

Review 2.  Genistein and cancer: current status, challenges, and future directions.

Authors:  Carmela Spagnuolo; Gian Luigi Russo; Ilkay Erdogan Orhan; Solomon Habtemariam; Maria Daglia; Antoni Sureda; Seyed Fazel Nabavi; Kasi Pandima Devi; Monica Rosa Loizzo; Rosa Tundis; Seyed Mohammad Nabavi
Journal:  Adv Nutr       Date:  2015-07-15       Impact factor: 8.701

3.  Protective effects of 7-difluoromethyl-5,4'-dimethoxygenistein against human aorta endothelial injury caused by lysophosphatidyl choline.

Authors:  Fei Liu; Jian-Guo Cao; Cheng Li; Jin-Seng Tan; Xiao-Hua Fu
Journal:  Mol Cell Biochem       Date:  2011-12-24       Impact factor: 3.396

4.  7-difluoromethoxyl-5,4'-di-n-octylgenistein inhibits growth of gastric cancer cells through downregulating forkhead box M1.

Authors:  Hong-Lin Xiang; Fei Liu; Mei-Fang Quan; Jian-Guo Cao; Yuan Lv
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

Review 5.  Multi-targeted therapy of cancer by genistein.

Authors:  Sanjeev Banerjee; Yiwei Li; Zhiwei Wang; Fazlul H Sarkar
Journal:  Cancer Lett       Date:  2008-05-19       Impact factor: 8.679

6.  Effect of 7-difluoromethyl-5, 4'-dimethoxygenistein on aorta atherosclerosis in hyperlipidemia ApoE(-/-) mice induced by a cholesterol-rich diet.

Authors:  Yong Zhang; Lesai Li; Jiliang You; Jianguo Cao; Xiaohua Fu
Journal:  Drug Des Devel Ther       Date:  2013-04-03       Impact factor: 4.162

7.  DFMG reverses proliferation and migration of vascular smooth muscle cells induced by co-culture with injured vascular endothelial cells via suppression of the TLR4-mediated signaling pathway.

Authors:  Li Cong; Yong Zhang; He Huang; Jianguo Cao; Xiaohua Fu
Journal:  Mol Med Rep       Date:  2018-02-26       Impact factor: 2.952

8.  DFMG attenuates the activation of macrophages induced by co‑culture with LPC‑injured HUVE‑12 cells via the TLR4/MyD88/NF‑κB signaling pathway.

Authors:  Li Cong; Shuting Yang; Yong Zhang; Jianguo Cao; Xiaohua Fu
Journal:  Int J Mol Med       Date:  2018-02-23       Impact factor: 4.101

9.  7‑Difluoromethyl‑5,4'‑dimethoxygenistein exerts anti‑angiogenic effects on acute promyelocytic leukemia HL‑60 cells by inhibiting the TLR4/NF‑κB signaling pathway.

Authors:  Xueping Xiang; Lesai Li; Pingjuan Bo; Ting Kuang; Sujuan Liu; Xiaolin Xie; Sihui Guo; Xiaohua Fu; Yong Zhang
Journal:  Mol Med Rep       Date:  2020-03-18       Impact factor: 3.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.